Sunscreen Secondary Claims: Market Differentiation or Market Confusion?

Current problems in dermatology Pub Date : 2021-01-01 Epub Date: 2021-10-25 DOI:10.1159/000517646
John A Staton
{"title":"Sunscreen Secondary Claims: Market Differentiation or Market Confusion?","authors":"John A Staton","doi":"10.1159/000517646","DOIUrl":null,"url":null,"abstract":"<p><p>This chapter is focused on those products that are sold primarily as sun protection products and considers the additional claims made for these that are intended to differentiate and imply additional benefits. It is essentially an overview, as each claim would require an individual chapter to deal with in detail. We do not consider products with another intended primary use, such as moisturizer or colour comments, which are, in themselves \"secondary sunscreens,\" defined specifically in Australia [AS/NZS 2604:2012 Sunscreen products - Evaluation and classification] or Canada. Primarily, the chapter serves as a reference guide. An argument is presented for the potential negative impact on the credibility of the whole product category brought about by the marketing strategy of attempting to segment on the basis of either criticism of competitor products and/or targeting niche groups of consumers. The European Union (EU) Regulation 655/2013 [Commission Regulation (EU) No 655/2013 laying down common criteria for the justification of claims used in relation to cosmetic products] states 6 criteria for representation of products. These are Legal Compliance, Truthfulness, Evidential Support, Honesty, Fairness and Informed Decision Making. More specifically to sunscreens, the EU Synthesis Document makes recommendation on efficacy and related claims [European Union Synthesis Document - Commission recommendation on the efficacy of sunscreen products and claims related thereto]. This chapter does not consider or test these criteria but does include a table of claims and suggested ways to substantiate these.</p>","PeriodicalId":11010,"journal":{"name":"Current problems in dermatology","volume":"55 ","pages":"385-393"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current problems in dermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000517646","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/10/25 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

This chapter is focused on those products that are sold primarily as sun protection products and considers the additional claims made for these that are intended to differentiate and imply additional benefits. It is essentially an overview, as each claim would require an individual chapter to deal with in detail. We do not consider products with another intended primary use, such as moisturizer or colour comments, which are, in themselves "secondary sunscreens," defined specifically in Australia [AS/NZS 2604:2012 Sunscreen products - Evaluation and classification] or Canada. Primarily, the chapter serves as a reference guide. An argument is presented for the potential negative impact on the credibility of the whole product category brought about by the marketing strategy of attempting to segment on the basis of either criticism of competitor products and/or targeting niche groups of consumers. The European Union (EU) Regulation 655/2013 [Commission Regulation (EU) No 655/2013 laying down common criteria for the justification of claims used in relation to cosmetic products] states 6 criteria for representation of products. These are Legal Compliance, Truthfulness, Evidential Support, Honesty, Fairness and Informed Decision Making. More specifically to sunscreens, the EU Synthesis Document makes recommendation on efficacy and related claims [European Union Synthesis Document - Commission recommendation on the efficacy of sunscreen products and claims related thereto]. This chapter does not consider or test these criteria but does include a table of claims and suggested ways to substantiate these.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
防晒霜二级声明:市场分化还是市场混乱?
本章主要关注那些主要作为防晒产品销售的产品,并考虑为这些产品做出的额外声明,这些声明旨在区分和暗示额外的好处。它本质上是一个概述,因为每个主张都需要单独的一章来详细处理。我们不考虑具有其他预期主要用途的产品,如保湿剂或颜色评论,这些产品本身是“二级防晒霜”,在澳大利亚[as /NZS 2604:2012防晒霜产品-评估和分类]或加拿大专门定义。本章主要作为参考指南。提出了一个论点,对整个产品类别的可信度的潜在负面影响带来的营销策略,试图细分的基础上,无论是对竞争对手的产品的批评和/或针对利基消费者群体。欧盟(EU)法规655/2013[欧盟委员会法规(EU) No 655/2013规定了与化妆品相关的声明证明的共同标准]规定了6个产品代表标准。这些原则是:守法、诚实、证据支持、诚实、公平和知情决策。更具体地说,欧盟综合文件对防晒产品的功效和相关声明提出了建议[欧盟综合文件-委员会对防晒产品功效和相关声明的建议]。本章不考虑或测试这些标准,但确实包括一个索赔表和证明这些标准的建议方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.90
自引率
0.00%
发文量
0
期刊最新文献
Auxiliary Utensils in Cosmetic and Medical Tattoo Settings. Static and Dynamic Anatomy of the Face, in Particular Eyebrows, Eyelids and Lips. Stretch Mark Treatment by Tattooing and Microneedling. On the Use, Effectiveness, and Safety of Face Masks, Gloves, and Disinfectants to Prevent Transfer of Microbials between the Tattooist and the Customer: A Practical Review of Pros and Cons Including the Occupational Safety of the Tattooist. Microblading Technique for Tattooing of "Hairstrokes" That Simulate Natural Hair: Eyebrow Tattooing and Correction of Medical Conditions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1